Effects of human papillomavirus type 16 oncoproteins on survivin gene expression

Journal of General Virology

Volumn 87, Issue 2, 2006, Pages 287-294

  Borbély, Ágnes A ^a   Murvai, Melinda ^b   Kónya, József ^a   Beck, Zoltán ^a   Gergely, Lajos ^a,b   Li, Fengzhi ^c   Veress, György ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; LUCIFERASE; MESSENGER RNA; ONCOPROTEIN; PROTEIN E6; PROTEIN E7; PROTEIN P53; SURVIVIN; UBIQUITIN; VIRUS PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL IMMORTALIZATION; CELL SYNCHRONIZATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HOST CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MALIGNANT NEOPLASTIC DISEASE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION; UTERINE CERVIX CANCER; VIRUS MUTANT;

APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PLASMIDS; REPRESSOR PROTEINS;

CANCER VIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 31644438582     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81067-0     Document Type: Article

References (31)

1. Aguilar-Lemarroy, A., Gariglio, P., Whitaker, N. J., Eichhorst, S. T., zur Hausen, H., Krammer, P. H. & Rosl, F. (2002). Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Oncogene 21, 165-175.
2. Alfandari, J., Shnitman Magal, S., Jackman, A., Schlegel, R., Gonen, P. & Sherman, L. (1999). HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes. Virology 257, 383-396.
3. Altieri, D. C. (2001). The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7, 542-547.
4. Ambrosini, G., Adida, C. & Altieri, D. C. (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3, 917-921.
5. Crook, T., Tidy, J. A. & Vousden, K. H. (1991). Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67, 547-556.
6. Cuconati, A. & White, E. (2002). Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Dev 16, 2465-2478.
7. Davies, R., Hicks, R., Crook, T., Morris, J. & Vousden, K. (1993). Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J Virol 67, 2521-2528.
8. Desaintes, C., Hallez, S., Van Alphen, P. & Burny, A. (1992). Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J Virol 66, 325-333.
9. Deveraux, Q. L. & Reed, J. C. (1999). IAP family proteins - suppressors of apoptosis. Genes Dev 13, 239-252.
10. Finzer, P., Aguilar-Lemarroy, A. & Rosl, F. (2002). The role of human papillomavirus oncoproteins E6 and E7 in apoptosis. Cancer Lett 188, 15-24.
11. Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E. & Shay, J. W. (1992). A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol 12, 2866-2871.
12. Halbert, C. L., Demers, G. W. & Galloway, D. A. (1991). The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol 65, 473-478.
13. Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J. & Murphy, M. (2002). Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277, 3247-3257.
14. Kim, H. S., Shiraki, K. & Park, S. H. (2002). Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res 22, 805-808.
15. Klingelhutz, A. J., Foster, S. A. & McDougall, J. K. (1996). Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79-82.
16. Li, F. (2005). Role of survivin and its splice variants in tumorigenesis. Br J Cancer 92, 212-216.
17. Li, F. & Altieri, D. C. (1999). Transcriptional analysis of human survivin gene expression. Biochem J 344, 305-311.
18. Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C. & Altieri, D. C. (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584.
19. Löhr, K., Moritz, C., Contente, A. & Dobbelstein, M. (2003). p21/ CDKN1A mediates negative regulation of transcription by p53. J Biol Chem 278, 32507-32516.
20. Lopez-Ocejo, O., Viloria-Petit, A., Bequet-Romero, M., Mukhopadhyay, D., Rak, J. & Kerbel, R. S. (2000). Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. Oncogene 19, 4611-4620.
21. Mirza, A., McGuirk, M., Hockenberry, T. N. & 10 other authors (2002). Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21, 2613-2622.
22. Münger, K. & Howley, P. M. (2002). Human papillomavirus immortalization and transformation functions. Virus Res 89, 213-228.
23. Münger, K., Basile, J. R., Duensing, S., Eichten, A., Gonzalez, S. L., Grace, M. & Zacny, V. L. (2001). Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20, 7888-7898.
24. Murvai, M., Borbély, A. A., Kónya, J., Gergely, L. & Veress, G. (2004). Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-β2 (TGF-β2) promoter. Arch Virol 149, 2379-2392.
25. Nees, M., Geoghegan, J. M., Munson, P., Prabhu, V., Liu, Y., Androphy, E. & Woodworth, C. D. (2000). Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-β2 in cervical keratinocytes. Cancer Res 60, 4289-4298.
26. Punga, T. & Akusjarvi, G. (2003). Adenovirus 2 E1B-55K protein relieves p53-mediated transcriptional repression of the survivin and MAP4 promoters. FEBS Lett 552, 214-218.
27. Rapp, L. & Chen, J. J. (1998). The papillomavirus E6 proteins. Biochim Biophys Acta 1378, 1-19.
28. Saitoh, Y., Yaginuma, Y. & Ishikawa, M. (1999). Analysis of Bcl-2, Bax and Survivin genes in uterine cancer. Int J Oncol 15, 137-141.
29. Sommer, K. W., Schamberger, C. J., Schmidt, G. E., Sasgary, S. & Cerni, C. (2003). Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras. Oncogene 22, 4266-4280.
30. Thomas, M., Kalita, A., Labrecque, S., Pim, D., Banks, L. & Matlashewski, G. (1999). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19, 1092-1100.
31. Zhu, Y., Roshal, M., Li, F., Blackett, J. & Planelles, V. (2003). Upregulation of survivin by HIV-1 Vpr. Apoptosis 8, 71-79.